Literature DB >> 818127

Recruitment and plasmapheresis of donors to provide human antitetanus immunoglobulin.

I A Cook, D W Ross, I Gordon.   

Abstract

A method is described whereby about 100 litres of plasma containing 10-50 IU/ml tetanus antitixin was obtained, from which were prepared 5000 X 250 IU doses of human antitetanus immunoglobulin. Of 40 blood donors who received a booster injection of tetanus vaccine BP, 33 were plasmapheresed each week over a 10-12 week period starting three weeks after the injection. Twenty-two of these donors provided 90% of the total plasma, the antitoxin content of which averaged 23.6 IU/ml over the 10-12 week period.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 818127      PMCID: PMC476023          DOI: 10.1136/jcp.29.3.211

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  COMBINED ACTIVE AND PASSIVE TETANUS PROPHYLAXIS: IMPORTANCE OF THE ANTIGENIC POTENCY OF TETANUS TOXOID.

Authors:  L A CHERNAYA; L G KOVTUNOVICH
Journal:  Fed Proc Transl Suppl       Date:  1963 Jul-Aug

2.  The selection of plasma for the preparation of antitetanus immunoglobulin.

Authors:  C C Entwistle; P L Eldridge
Journal:  Vox Sang       Date:  1973-09       Impact factor: 2.144

3.  [Several problems in obtaining anti-tetanus gamma globulin from blood donors revaccinated with purified adsorbed tetanus anatoxin].

Authors:  G F Papko; B D Bychenko; K I Matveev; S V Skurkovich; E N Lukovkina
Journal:  Probl Gematol Pereliv Krovi       Date:  1970-11

4.  Automated screening test for high titre tetanus antibody in donor plasma.

Authors:  M Nelson
Journal:  Vox Sang       Date:  1973-11       Impact factor: 2.144

5.  Outdated blood and placental extracts as a source for diphtheria and tetanus immune globulin (human).

Authors:  J T Sgouris; F Angela; R Y Gottshall
Journal:  Vox Sang       Date:  1966 Mar-Apr       Impact factor: 2.144

6.  Progress in tetanus prophylaxis: the advent of human antitoxin.

Authors:  B J Perey
Journal:  Can Med Assoc J       Date:  1966-02-26       Impact factor: 8.262

7.  Tetanus immune globulin (human) in prophylaxis against tetanus.

Authors:  H C Shirkey
Journal:  J Pediatr       Date:  1965-10       Impact factor: 4.406

  7 in total
  1 in total

1.  Screening of blood donors for the detection of antitetanus antibodies suitable for the production of human antitetanus immunoglobulin.

Authors:  I C Wiseman; M E Gascoigne
Journal:  J Clin Pathol       Date:  1977-02       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.